Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia

NCT05639673 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05639673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05639673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Unknown status
Start date
June 15, 2023
Completion date
November 1, 2025
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia